Bill & Melinda Gates Foundation — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.
BiotechDeep TechHealthtechBoston, US
Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)
Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines.
BiotechHealthtechRedmond, US
Subhash Kapre(Manager, Co-CEO)inPradip Ghate(Chief Operating Officer)inDavid Goesling(Chief Financial Officer)inYves Leurquin(Manager, Co-CEO)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.